Nearly 1/3 of the world’s newborn deaths occur in India where 58,000 babies die annually from superbugs.
With that number bound to increase, "India is absolutely in the frontline for the problem of antibiotic resistance globally," says Ramanan Laxminarayan, director of the Centre for Disease Dynamics, Economics and Policy, based in New Delhi and Washington DC.
Recent successes in reducing the country's infant mortality rate are at risk. And the rise of antibiotic-resistant bacteria threatens to extend far beyond India's borders. Researchers have found that at least 1 antibiotic-resistant bacteria first identified in India has now spread to more than 70 countries.